PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa. Electronic address: 22820388@g.nwu.ac.za.\', \'Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.\', \'Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa; South African MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. Electronic address: Brian.Harvey@nwu.ac.za.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(20)31393-710.1016/j.biopha.2020.111200
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 33421734
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all